Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick?

Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):478-486. doi: 10.1182/hematology.2020000132.

Abstract

While iron deficiency remains the most common cause of anemia worldwide, low iron stores are associated with symptoms regardless of the presence of typical microcytic, hypochromic anemia and may be hard to recognize in patients with concurrent inflammation. Diagnosing and treating iron deficiency become more of a challenge because markers of iron status are influenced by low-grade inflammation present in common conditions, such as chronic kidney disease, cirrhosis, or heart failure. Here I present a pragmatic way of interpreting diagnostic lab tests to help clinicians recognize patients who are most likely to benefit from iron supplementation, choose between oral and parenteral administration, and make personalized decisions when patients do not fit usual guidelines.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Biomarkers / metabolism
  • Chronic Disease
  • Female
  • Fibrosis / diagnosis
  • Fibrosis / metabolism
  • Fibrosis / therapy
  • Heart Failure* / diagnosis
  • Heart Failure* / metabolism
  • Heart Failure* / therapy
  • Humans
  • Inflammation / diagnosis
  • Inflammation / metabolism
  • Inflammation / therapy
  • Iron Deficiencies
  • Iron* / metabolism
  • Iron* / therapeutic use
  • Middle Aged
  • Renal Insufficiency, Chronic* / diagnosis
  • Renal Insufficiency, Chronic* / metabolism
  • Renal Insufficiency, Chronic* / therapy

Substances

  • Biomarkers
  • Iron